Main competitors
Dividend Yield (N) Dividend Yield (N+1) P/E (N) Price to Book (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Capi.($)
- - - - - - - 28Cr
0.68%0.75%28.72x17.7x10.82x21.74x23.15x 87TCr
2.19%2.31%25.68x6.67x5.98x16.28x17.98x 58TCr
3.08%3.2%24.62x60.6x6.7x13.46x13.8x 40TCr
3.16%3.24%17.19x6.1x4.19x10.36x11.73x 32TCr
1.73%1.84%24.12x5.46x5.03x13.93x14.94x 30TCr
2.86%3%20.99x6.21x5.66x13.99x14.96x 29TCr
2.91%3%27.09x5.07x4.75x14.85x17.55x 29TCr
2.73%2.91%24.74x16.62x6.28x11.18x14.27x 20TCr
2.24%2.48%20.13x6.82x6.12x11.08x13.04x 18TCr
6.55%6.58%12.57x1.68x3.19x7.6x8.99x 15TCr
-.--%-.--%27.27x5.36x8.29x18.51x19.23x 12TCr
4.27%4.39%11.79x5.15x3.11x8.37x8.99x 12TCr
3.41%3.75%12.75x4.33x2.76x7.99x9.17x 11TCr
5.54%5.9%12.05x1.19x2.21x7.27x7.9x 11TCr
2.69%1.45%36.25x7.84x11.73x23.04x24.57x 9.75TCr
3.53%3.59%50.67x1.29x2.84x10.51x29.89x 5.62TCr
0.48%0.55%42.53x6.02x9.94x33.6x34.94x 5.34TCr
0.56%2.04%31.67x1.35x1.56x7.45x12.55x 4.43TCr
Average 2.7% 2.83% 25.05x 9.19x 5.62x 13.96x 16.54x 22.61TCr
Weighted average by Cap. 2.38% 2.49% 24.31x 13.55x 6.55x 15.11x 16.80x
Other Pharmaceuticals
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW